Value Aligned Research Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.9M Sell
115,078
-26,331
-19% -$4.28M 0.08% 74
2025
Q4
$27.6M Buy
+141,409
New +$33.7M 0.28% 49
2025
Q2
Sell
-1,555
Closed -$251K 83
2025
Q1
$217K Buy
+1,555
New +$253K 0.02% 56

Other funds holding ORCL

Value Aligned Research Advisors's ORCL Position: Q1 2026 in Review

Value Aligned Research Advisors reduced its Oracle (ORCL) stake by 19% in Q1 2026, selling an estimated $4.28M and leaving 115,078 shares worth $16.9M. The position accounts for 0.08% of the portfolio, ranked #74.

Value Aligned Research Advisors first reported a position in ORCL in Q1 2025 and has held it in 3 quarters since. The position peaked at $27.6M in Q4 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Value Aligned Research Advisors held 115,078 shares of Oracle worth $16.9M as of Q1 2026.
  • Value Aligned Research Advisors sold 26,331 Oracle shares in Q1 2026, an estimated $4.28M.
  • Oracle made up 0.08% of Value Aligned Research Advisors's portfolio in Q1 2026, its #74 holding.
  • Value Aligned Research Advisors first reported a position in Oracle in Q1 2025 and has held it in 3 quarters since.
  • Value Aligned Research Advisors's Oracle position peaked at $27.6M in Q4 2025.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.